Latest Form 4 insider transactions

Janice L. Meyer, a Director of Cheesecake Factory Inc, sold 1,958 shares of common stock on August 17, 2026 for $109.36 per share.

Andrew D Dickinson, Chief Financial Officer of Gilead Sciences, Inc., sold 3,000 shares of common stock on August 17, 2026 for $138.36 per share.

Nimrod Ben-Natan, President and CEO and a Director of Harmonic Inc, reported multiple transactions in common stock on August 15, 2026.

Laura Boettcher, Chief Operating Officer of Hippo Holdings Inc., reported a transaction in 1,586 shares of common stock on August 15, 2026.

Torben Ostergaard, CEO Spinnaker of Hippo Holdings Inc., sold 1,169 shares of common stock on August 15, 2026 for $33.00 per share.

Michael Stienstra, GM & Chief Insurance, HHIP of Hippo Holdings Inc., reported a transaction in 1,259 shares of common stock on August 15, 2026.

Gary Scott Giesler, Chief Legal Officer, Secretary of Grove Collaborative Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Guy Zeltser, Chief Financial Officer of Hippo Holdings Inc., reported a transaction in 3,945 shares of common stock on August 15, 2026.

Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 15,000 shares of common stock on August 17, 2026 for $27.48 per share.

Michael Gathy, Chief Accounting Officer of Lazard, Inc., received 145 shares of common stock on August 14, 2026.

Christopher Hogbin, CEO Asset Management of Lazard, Inc., received 2,954 shares of common stock on August 14, 2026.

Alexandra Soto, Chief Operating Officer of Lazard, Inc., received 3,413 shares of common stock on August 14, 2026.

Tracy Farr, Chief Financial Officer of Lazard, Inc., received 426 shares of common stock on August 14, 2026.

Thomas Siragusa, CFO of Grove Collaborative Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

John D Quisel, Chief Executive Officer and a Director of Disc Medicine, Inc., sold 33,000 shares of common stock on August 17, 2026.

John Wayne Witt, Vice President of Kennametal Inc, reported multiple transactions in common stock on August 14, 2026.

Catalyst4, Inc. reported changes in beneficial ownership of MapLight Therapeutics, Inc. common stock on August 14, 2026.

Lozano Rogelio Zambrano, a Director of Cemex Sab De Cv, reported multiple transactions in common stock on August 14, 2026.

Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, Inc., sold 28,000 shares of common stock on August 17, 2026.

John Caplan, Chief Executive Officer and a Director of Payoneer Global Inc., reported a transaction in 25,873 shares of common stock on August 17, 2026.

Christopher B Paisley, a Director of Equinix Inc, sold 125 shares of common stock on August 18, 2026 for $1,103.58 per share.

Vyacheslav Kim, a Director of Joint Stock Co Kaspi.kz, sold 56,376 shares of common stock on August 14, 2026.

John L. Brottem, General Counsel of Outset Medical, Inc., sold 2,632 shares of common stock on August 17, 2026 for $4.39 per share.

Beatrice Ordonez, Chief Financial Officer of Payoneer Global Inc., reported a transaction in 12,321 shares of common stock on August 17, 2026.

Jeffrey Michael Yurcisin, President & CEO and a Director of Grove Collaborative Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Diya Jolly, a Director of Appfolio Inc, reported multiple transactions in common stock on June 29, 2026.

Vishal Talwar, EVP CDIO & PRESIDENT FDW of Fedex Corp, received 1,489 shares of common stock on August 17, 2026.

Tsafi Goldman, Chief Legal & Governance Ofcr of Payoneer Global Inc., reported a transaction in 6,160 shares of common stock on August 17, 2026.

Richard Mccathron, Chief Executive Officer and a Director of Hippo Holdings Inc., reported a transaction in 8,301 shares of common stock on August 15, 2026.

Renee Gaeta, Chief Financial Officer of Outset Medical, Inc., sold 4,543 shares of common stock on August 17, 2026 for $4.39 per share.